Takeda Pharmaceutical Co Ltd

Company Profile

• Business description

  Takeda Pharmaceutical is Japan’s largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company’s five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.

• Contact

  1-1, Nihonbashi-Honcho 2-Chome
  Chuo-ku
  Tokyo103-8668
  JPN

  T: +81 332782306

  E: [email protected]

  https://www.takeda.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Drug Manufacturers - Specialty & Generic

  Fiscal Year End

  31 March 2027

  Employees

  47,455